Annual Shareholders Equity
$9.80 M
-$3.85 M-28.22%
December 1, 2023
Summary
- As of February 8, 2025, XBIO annual stockholders equity is $9.80 million, with the most recent change of -$3.85 million (-28.22%) on December 1, 2023.
- During the last 3 years, XBIO annual shareholders equity has fallen by -$2.42 million (-19.81%).
- XBIO annual shareholders equity is now -52.86% below its all-time high of $20.78 million, reached on December 1, 2012.
Performance
XBIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$7.04 M
-$409.10 K-5.49%
September 1, 2024
Summary
- As of February 8, 2025, XBIO quarterly stockholders equity is $7.04 million, with the most recent change of -$409.10 thousand (-5.49%) on September 1, 2024.
- Over the past year, XBIO quarterly shareholders equity has dropped by -$1.64 million (-18.91%).
- XBIO quarterly shareholders equity is now -65.10% below its all-time high of $20.16 million, reached on September 30, 2021.
Performance
XBIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XBIO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.2% | -18.9% |
| 3 y3 years | -19.8% | -40.8% |
| 5 y5 years | -1.2% | -40.8% |
XBIO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | at low | -61.8% | at low |
| 5 y | 5-year | -46.8% | at low | -65.1% | at low |
| alltime | all time | -52.9% | +5479.2% | -65.1% | +2760.3% |
Xenetic Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.04 M(-5.5%) |
| Jun 2024 | - | $7.45 M(-14.2%) |
| Mar 2024 | - | $8.68 M(-11.4%) |
| Dec 2023 | $9.80 M(-28.2%) | $9.80 M(-10.1%) |
| Sep 2023 | - | $10.89 M(-8.3%) |
| Jun 2023 | - | $11.88 M(-7.6%) |
| Mar 2023 | - | $12.86 M(-5.8%) |
| Dec 2022 | $13.65 M(-25.8%) | $13.65 M(-6.0%) |
| Sep 2022 | - | $14.52 M(-4.4%) |
| Jun 2022 | - | $15.19 M(-10.2%) |
| Mar 2022 | - | $16.92 M(-8.0%) |
| Dec 2021 | $18.39 M(+50.6%) | $18.39 M(-8.8%) |
| Sep 2021 | - | $20.16 M(+102.7%) |
| Jun 2021 | - | $9.95 M(-9.1%) |
| Mar 2021 | - | $10.95 M(-10.4%) |
| Dec 2020 | $12.22 M(-29.0%) | $12.22 M(+54.5%) |
| Sep 2020 | - | $7.91 M(-48.5%) |
| Jun 2020 | - | $15.36 M(-5.2%) |
| Mar 2020 | - | $16.20 M(-5.9%) |
| Dec 2019 | $17.21 M(+73.6%) | $17.21 M(-5.7%) |
| Sep 2019 | - | $18.26 M(+75.7%) |
| Jun 2019 | - | $10.39 M(-9.8%) |
| Mar 2019 | - | $11.52 M(+16.2%) |
| Dec 2018 | $9.91 M(-30.7%) | $9.91 M(-12.2%) |
| Sep 2018 | - | $11.30 M(-11.6%) |
| Jun 2018 | - | $12.78 M(-0.8%) |
| Mar 2018 | - | $12.89 M(-9.9%) |
| Dec 2017 | $14.30 M | $14.30 M(+49.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $9.55 M(-17.0%) |
| Jun 2017 | - | $11.51 M(-17.2%) |
| Mar 2017 | - | $13.90 M(-14.0%) |
| Dec 2016 | $16.17 M(+144.7%) | $16.17 M(+171.6%) |
| Sep 2016 | - | $5.95 M(-7.1%) |
| Jun 2016 | - | $6.41 M(+26.7%) |
| Mar 2016 | - | $5.06 M(-23.4%) |
| Dec 2015 | $6.61 M(-36.9%) | $6.61 M(+27.5%) |
| Sep 2015 | - | $5.18 M(-24.2%) |
| Jun 2015 | - | $6.83 M(-16.7%) |
| Mar 2015 | - | $8.21 M(-21.7%) |
| Dec 2014 | $10.48 M(-16.9%) | $10.48 M(-25.2%) |
| Sep 2014 | - | $14.02 M(-19.9%) |
| Jun 2014 | - | $17.49 M(-11.7%) |
| Mar 2014 | - | $19.81 M(-7590.0%) |
| Dec 2013 | $12.62 M(-7029.0%) | - |
| Nov 2013 | - | -$264.50 K(+45.2%) |
| Aug 2013 | - | -$182.10 K(+71.8%) |
| Aug 2013 | -$182.10 K(-100.9%) | - |
| May 2013 | - | -$106.00 K(+14.8%) |
| Feb 2013 | - | -$92.30 K(-14.1%) |
| Dec 2012 | $20.78 M(<-9900.0%) | - |
| Nov 2012 | - | -$107.40 K(+15.6%) |
| Aug 2012 | - | -$92.90 K(+87.7%) |
| Aug 2012 | -$92.90 K(-5261.1%) | - |
| May 2012 | - | -$49.50 K(+8.3%) |
| Feb 2012 | - | -$45.70 K |
| Aug 2011 | $1800.00 | - |
FAQ
- What is Xenetic Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Xenetic Biosciences?
- What is Xenetic Biosciences annual shareholders equity year-on-year change?
- What is Xenetic Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly shareholders equity year-on-year change?
What is Xenetic Biosciences annual stockholders equity?
The current annual shareholders equity of XBIO is $9.80 M
What is the all time high annual shareholders equity for Xenetic Biosciences?
Xenetic Biosciences all-time high annual stockholders equity is $20.78 M
What is Xenetic Biosciences annual shareholders equity year-on-year change?
Over the past year, XBIO annual stockholders equity has changed by -$3.85 M (-28.22%)
What is Xenetic Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of XBIO is $7.04 M
What is the all time high quarterly shareholders equity for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly stockholders equity is $20.16 M
What is Xenetic Biosciences quarterly shareholders equity year-on-year change?
Over the past year, XBIO quarterly stockholders equity has changed by -$1.64 M (-18.91%)